Interstitial lung disease and neuropathy as predominant extra-articular manifestations in patients with rheumatoid arthritis: a prospective study.

Med Sci Monit

Department of Immunology, Rheumatology, Charaka Express, Kasturba Medical College, Manipal, Udupi District, Karnataka, India.

Published: October 2005

Background: Rheumatoid arthritis (RA) patients with extra-articular manifestations (ExRA) have a severe course of the disease and higher mortality. Indian patients are considered to have a low prevalence of ExRA. We prospectively assessed ExRA in patients with rheumatoid arthritis from southern India.

Material/methods: 140 RA patients were qualified for the study. Patients with confounding factors were excluded. A detailed history and clinical examination was performed. Two independent investigators made a thorough search with relevant investigations for ExRA, according to well-defined criteria.

Results: At least one ExRA was present in 36 patients (25.7%). The predominant ExRA (9.29%) was Interstitial Lung Disease (ILD). 12 patients had neuropathy (8.57%). 5 patients had eye involvement, while 3 had cutaneous vasculitis. 4 patients had rheumatoid nodules, and 1 had amyloidosis. The median age at diagnosis and duration of disease were significantly higher in patients with ExRAs than in those without. Deformities and the use of steroids were more common in the ExRA cohort.

Conclusions: The present study shows a high prevalence of ILD and neuropathy as ExRAs in our population. A more extensive investigative protocol is warranted for picking up milder presentations of these serious manifestations.

Download full-text PDF

Source

Publication Analysis

Top Keywords

patients rheumatoid
12
rheumatoid arthritis
12
patients
11
interstitial lung
8
lung disease
8
extra-articular manifestations
8
disease higher
8
exra patients
8
exra
7
disease
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!